PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo

Overview

Journal ACS Nano

Publisher American Chemical Society

Specialty Biotechnology

Date 2022 Oct 27

PMID 36301574

Authors

Sandra Hocevar

Viola Puddinu

Laetitia Haeni

Alke Petri-Fink

Julia Wagner

Montserrat Alvarez

Martin James David Clift

Carole Bourquin

Affiliations

Soon will be listed here.

Abstract

Engineered gold nanoparticles (GNPs) have become a useful tool in various therapeutic and diagnostic applications. Uncertainty remains regarding the possible impact of GNPs on the immune system. In this regard, we investigated the interactions of polymer-coated GNPs with B cells and their functions in mice. Surprisingly, we observed that polymer-coated GNPs mainly interact with the recently identified subpopulation of B lymphocytes named age-associated B cells (ABCs). Importantly, we also showed that GNPs did not affect cell viability or the percentages of other B cell populations in different organs. Furthermore, GNPs did not activate B cell innate-like immune responses in any of the tested conditions, nor did they impair adaptive B cell responses in immunized mice. Together, these data provide an important contribution to the otherwise limited knowledge about GNP interference with B cell immune function, and demonstrate that GNPs represent a safe tool to target ABCs for potential clinical applications.

Citing Articles

GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model.

Boersma B, Puddinu V, Huard A, Fauteux-Daniel S, Wirapati P, Guedri S Front Immunol. 2024; 15:1396777.

PMID: 39224600 PMC: 11366651. DOI: 10.3389/fimmu.2024.1396777.

Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond.

Hsu J, Liu P, Song Y, Song W, Saladin R, Peng Y Chem Soc Rev. 2024; 53(15):7657-7680.

PMID: 38958009 PMC: 11334694. DOI: 10.1039/d4cs00421c.

Targeting T-bet expressing B cells for therapeutic interventions in autoimmunity.

Sachinidis A, Lamprinou M, Dimitroulas T, Garyfallos A Clin Exp Immunol. 2024; 217(2):159-166.

PMID: 38647337 PMC: 11239558. DOI: 10.1093/cei/uxae036.

Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants.

Vinuesa C, Shen N, Ware T Nat Rev Nephrol. 2023; 19(9):558-572.

PMID: 37438615 DOI: 10.1038/s41581-023-00732-x.

Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target.

Li Z, Cai M, Qin Y, Chen Z Front Immunol. 2023; 14:1103307.

PMID: 36817481 PMC: 9933781. DOI: 10.3389/fimmu.2023.1103307.

References

Adlowitz D, Barnard J, Biear J, Cistrone C, Owen T, Wang W . Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response. PLoS One. 2015; 10(6):e0128269. PMC: 4457888. DOI: 10.1371/journal.pone.0128269. View

Mellman I, Plutner H, Ukkonen P . Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment. J Cell Biol. 1984; 98(4):1163-9. PMC: 2113231. DOI: 10.1083/jcb.98.4.1163. View

Rodriguez-Lorenzo L, Fytianos K, Blank F, von Garnier C, Rothen-Rutishauser B, Petri-Fink A . Fluorescence-encoded gold nanoparticles: library design and modulation of cellular uptake into dendritic cells. Small. 2014; 10(7):1341-50. DOI: 10.1002/smll.201302889. View

Chen Y, Hung Y, Lin W, Huang G . Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology. 2010; 21(19):195101. DOI: 10.1088/0957-4484/21/19/195101. View

Ma S, Wang C, Mao X, Hao Y . B Cell Dysfunction Associated With Aging and Autoimmune Diseases. Front Immunol. 2019; 10:318. PMC: 6400972. DOI: 10.3389/fimmu.2019.00318. View

Lee C, Syu S, Chen Y, Hussain S, Aleksandrovich Onischuk A, Chen W . Gold nanoparticles regulate the blimp1/pax5 pathway and enhance antibody secretion in B-cells. Nanotechnology. 2014; 25(12):125103. DOI: 10.1088/0957-4484/25/12/125103. View

Jenks S, Cashman K, Zumaquero E, Marigorta U, Patel A, Wang X . Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 2018; 49(4):725-739.e6. PMC: 6217820. DOI: 10.1016/j.immuni.2018.08.015. View

Malaczewska J . Effect of oral administration of commercial gold nanocolloid on peripheral blood leukocytes in mice. Pol J Vet Sci. 2015; 18(2):273-82. DOI: 10.1515/pjvs-2015-0036. View

Zhu Q, Zhang M, Shi M, Liu Y, Zhao Q, Wang W . Human B cells have an active phagocytic capability and undergo immune activation upon phagocytosis of Mycobacterium tuberculosis. Immunobiology. 2016; 221(4):558-67. DOI: 10.1016/j.imbio.2015.12.003. View

10.

Vu V, Gifford G, Chen F, Benasutti H, Wang G, Groman E . Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nat Nanotechnol. 2019; 14(3):260-268. PMC: 6402998. DOI: 10.1038/s41565-018-0344-3. View

11.

Shimizu T, Mima Y, Hashimoto Y, Ukawa M, Ando H, Kiwada H . Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells. Immunobiology. 2015; 220(10):1151-60. DOI: 10.1016/j.imbio.2015.06.005. View

12.

Song W, Antao O, Condiff E, Sanchez G, Chernova I, Zembrzuski K . Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers. Immunity. 2022; 55(2):290-307.e5. PMC: 8965751. DOI: 10.1016/j.immuni.2022.01.002. View

13.

Martinez-Riano A, Bovolenta E, Mendoza P, Oeste C, Martin-Bermejo M, Bovolenta P . Antigen phagocytosis by B cells is required for a potent humoral response. EMBO Rep. 2018; 19(9). PMC: 6123646. DOI: 10.15252/embr.201846016. View

14.

Naradikian M, Myles A, Beiting D, Roberts K, Dawson L, Herati R . Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. J Immunol. 2016; 197(4):1023-8. PMC: 4975960. DOI: 10.4049/jimmunol.1600522. View

15.

Cheng Y, Riviere J, Monteiro-Riviere N, Lin Z . Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling. Nanotoxicology. 2018; 12(5):453-469. PMC: 6051695. DOI: 10.1080/17435390.2018.1459922. View

16.

Hong S, Zhang Z, Liu H, Tian M, Zhu X, Zhang Z . B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4 T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen. Immunity. 2018; 49(4):695-708.e4. DOI: 10.1016/j.immuni.2018.08.012. View

17.

Khlebtsov N, Dykman L . Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2010; 40(3):1647-71. DOI: 10.1039/c0cs00018c. View

18.

Feldman A, Wolfe D . Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 2014; 1180:31-43. DOI: 10.1007/978-1-4939-1050-2_3. View

19.

Climent N, Garcia I, Marradi M, Chiodo F, Miralles L, Maleno M . Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses. Nanomedicine. 2017; 14(2):339-351. DOI: 10.1016/j.nano.2017.11.009. View

20.

Puddinu V, Casella S, Radice E, Thelen S, Dirnhofer S, Bertoni F . ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration. Oncotarget. 2017; 8(49):85068-85084. PMC: 5689594. DOI: 10.18632/oncotarget.18844. View